Cellebrite DI Ltd. (NASDAQ:CLBT) Shares Sold by Hsbc Holdings PLC

Hsbc Holdings PLC decreased its position in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 45.0% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 52,317 shares of the company's stock after selling 42,770 shares during the period. Hsbc Holdings PLC's holdings in Cellebrite DI were worth $1,136,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. True Wind Capital Management L.P. raised its holdings in Cellebrite DI by 18.2% in the 4th quarter. True Wind Capital Management L.P. now owns 13,861,007 shares of the company's stock worth $305,358,000 after purchasing an additional 2,130,386 shares during the period. FMR LLC raised its stake in shares of Cellebrite DI by 89.1% during the 4th quarter. FMR LLC now owns 10,621,344 shares of the company's stock worth $233,988,000 after buying an additional 5,004,587 shares during the period. Voss Capital LP lifted its position in shares of Cellebrite DI by 1.2% during the 4th quarter. Voss Capital LP now owns 3,240,000 shares of the company's stock valued at $71,377,000 after buying an additional 39,700 shares in the last quarter. Pertento Partners LLP grew its stake in Cellebrite DI by 26.7% in the 4th quarter. Pertento Partners LLP now owns 2,975,374 shares of the company's stock valued at $65,547,000 after acquiring an additional 626,373 shares during the period. Finally, Pembroke Management LTD raised its position in Cellebrite DI by 4.4% during the fourth quarter. Pembroke Management LTD now owns 1,992,432 shares of the company's stock worth $43,893,000 after acquiring an additional 84,087 shares during the period. Institutional investors and hedge funds own 45.88% of the company's stock.

Wall Street Analyst Weigh In

CLBT has been the subject of a number of research reports. JPMorgan Chase & Co. boosted their target price on shares of Cellebrite DI from $24.00 to $28.00 and gave the stock an "overweight" rating in a research note on Tuesday, February 11th. Needham & Company LLC restated a "buy" rating and issued a $28.00 target price on shares of Cellebrite DI in a research report on Wednesday, April 2nd. Finally, Lake Street Capital boosted their price target on Cellebrite DI from $17.00 to $26.00 and gave the stock a "buy" rating in a research report on Friday, February 14th. Seven investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock has an average rating of "Buy" and an average price target of $23.43.

Cellebrite DI Price Performance

Cellebrite DI stock traded down $0.39 during trading on Wednesday, reaching $19.08. 1,067,239 shares of the company were exchanged, compared to its average volume of 1,419,646. The stock's 50 day simple moving average is $18.86 and its two-hundred day simple moving average is $20.21. The company has a market capitalization of $4.57 billion, a P/E ratio of -13.73, a PEG ratio of 4.27 and a beta of 1.44. Cellebrite DI Ltd. has a 52-week low of $10.25 and a 52-week high of $26.30.

Cellebrite DI (NASDAQ:CLBT - Get Free Report) last announced its quarterly earnings data on Thursday, February 13th. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.10 by ($0.03). Cellebrite DI had a negative net margin of 70.54% and a positive return on equity of 58.70%. As a group, equities analysts forecast that Cellebrite DI Ltd. will post 0.3 earnings per share for the current year.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.